Scientists say they have identified urine bacteria which are linked to aggressive prostate cancer. The discovery might provide new ways to spot and even prevent these dangerous tumours, experts hope. It’s too soon to say if the bacteria might cause the cancer, rather than just be a helpful marker. Read the article here.
Urine bugs may be a sign of aggressive prostate cancer Read More »
On July 29, 2021, Drs. Ming Zhou, Pathologist-in-Chief and Chair of Anatomic and Clinical Pathology, Tufts Medical School, and Dr. Scott Eggener, Vice Chair of Urology at the University of Chicago, debated this question: Is Gleason 6 a cancer? The doctors presented their cases at the AnCan program in this video individually. One of Eggener’s key points is that he has never seen a patient die from Gleason 6 so why call it a cancer. Zhou took the stand that if it looks like a cancer, which Gleason does under the microscope, then it’s a cancer. The question-and-answer period covered such
Is Gleason 6 a cancer? Read More »
Video is now available of the fourth webinar in Us TOO‘s series, What is Right for Me in My Prostate Cancer Treatment?, a discussion on Imaging. Continuing advances in imaging technology and usage can mean more accurate testing and diagnosis related to prostate cancer, and can help guide patients toward the best treatment options for them. Hear the latest from the experts on this very important topic. This webinar was recorded on June 24th. View the Video here. Featuring: Brian T. Helfand MD, PhD – Chief, Division of Urology, Ronald L. Chez Family and Richard Melman Family Endowed Chair of
What is Right for Me in My Prostate Cancer Treatment? Read More »
Abstract Objectives Limited data are available concerning the extent to which the initial prostate-specific antigen (PSA) measurement in men younger than age 60 predicts for the risk of prostate cancer (CaP) and how this compares to other known risk factors. Methods From 1991 to 2001, 13,943 men younger than 60 years old participated in a CaP screening study. Men aged 40 to 49 years were eligible for the study if they had a positive family history or African-American heritage, and men older than 50 years were screened without respect to risk factors. The CaP detection rate, PSA velocity, pathologic features,
Tide of opinion turning again In 2012, the U.S. Preventive Services Task Force (USPSTF) — a powerful, voluntary group that sets guidelines for primary care physicians — came out against the mass screening of healthy men with prostate-specific antigen (PSA) blood tests for the early detection of prostate cancer. That statement, which was somewhat reversed in 2018, has lived on and continues to fuel hot debates over the use of screening and whether the guidelines themselves caused more harm than benefit. And there likely will be more arguments in the years ahead as medical groups conduct uptakes on guidelines and
The Swinging Pendulum of PSA Screening Read More »
“The Talk” is not about the birds and the bees; it’s about talking to your sons and daughters about possibly inheriting genes that predispose them to prostate and breast cancer. View video.
“The Talk” Webinar Video Read More »
Benefits of PSA Test for Prostate Cancer Substantially Greater than Generally Appreciated The benefits of the prostate-specific antigen (PSA) test to screen men for prostate cancer may be greater than the harm, say investigators at Weill Cornell Medicine, NewYork-Presbyterian, University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. While organizations such as the U.S. Preventative Services Task Force (USPSTF) and the American Academy of Family Physicians have been lukewarm or opposed to the routine use of the PSA test, in a commentary published in the New England Journal of Medicine, the investigators demonstrate that these recommendations
A Re-think About PSA Testing Read More »
A new type of test that uses complex sugars to detect prostate cancer earlier and with greater accuracy is being developed by researchers at the University of Birmingham. The test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo distinct but subtle changes when cancer is present in the body. Read the article.
New test may help detect prostate cancer earlier and with greater accuracy Read More »
A new vaccine may one day delay the need to use ADT by harnessing patients’ immune systems, researchers reported at the 34th Annual Meeting & Preconference Programs of the Society for Immunotherapy of Cancer, or SITC 2019, which occurred in Maryland in November 2019. Read the article.
New Vaccine Could Delay ADT Use in Stage D0 Prostate Cancer Read More »
July 2019 Awareness Night Imaging in Prostate Cancer, The Whats, Wheres, Whys and Whens Dr. Chirag Patel,]BSc (Hons), MBBS, MRCP, FRCR Asst Prof., U. of Toronto Dept of Medical Imaging Site Lead, U. of Toronto Abdominal Imaging Fellowship Program Abdominal Radiologist and Head of Abdominal Imaging Division, Sunnybrook Health Sciences Centre, Dept of Medical Imaging CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 1:06:02 minutes <
Video: “Imaging in Prostate Cancer” Read More »